Pharma Friday – Oct. 2, 2026
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves First Treatment for MCT8 Deficiency On Sept. 28, the U.S. Food and Drug Administration (FDA) approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid […]
The post Pharma Friday – Oct. 2, 2026 appeared first on Endocrine News.
Apa Reaksi Anda?
Suka
0
Kurang Suka
0
Setuju
0
Tidak Setuju
0
Bagus
0
Berguna
0
Hebat
0
